Goldman Sachs Group Inc Biolife Solutions Inc Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 378,148 shares of BLFS stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
378,148
Previous 193,917 95.01%
Holding current value
$10.3 Million
Previous $4.85 Million 102.27%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$20.47 - $27.47 $3.77 Million - $5.06 Million
184,231 Added 95.01%
378,148 $9.82 Million
Q3 2024

Nov 14, 2024
BUY
$19.19 - $26.52 $1.48 Million - $2.05 Million
77,225 Added 66.18%
193,917 $4.85 Million
Q2 2024

Aug 13, 2024
SELL
$15.14 - $22.99 $463,980 - $704,551
-30,646 Reduced 20.8%
116,692 $2.5 Million
Q1 2024

May 15, 2024
SELL
$15.35 - $18.82 $34.6 Million - $42.4 Million
-2,254,561 Reduced 93.87%
147,338 $2.73 Million
Q4 2023

Feb 13, 2024
BUY
$8.99 - $16.86 $19.7 Million - $36.9 Million
2,191,002 Added 1038.9%
2,401,899 $39 Million
Q3 2023

May 14, 2024
SELL
$10.81 - $22.96 $23.7 Million - $50.3 Million
-2,191,002 Reduced 91.22%
210,897 $2.91 Million
Q3 2023

Nov 14, 2023
BUY
$10.81 - $22.96 $1.12 Million - $2.38 Million
103,612 Added 96.58%
210,897 $2.91 Million
Q2 2023

May 14, 2024
SELL
$17.19 - $24.34 $244,648 - $346,406
-14,232 Reduced 11.71%
107,285 $2.37 Million
Q2 2023

Aug 14, 2023
SELL
$17.19 - $24.34 $244,648 - $346,406
-14,232 Reduced 11.71%
107,285 $2.37 Million
Q1 2023

May 14, 2024
BUY
$17.67 - $26.07 $180,658 - $266,539
10,224 Added 9.19%
121,517 $2.64 Million
Q1 2023

May 11, 2023
BUY
$17.67 - $26.07 $180,658 - $266,539
10,224 Added 9.19%
121,517 $2.64 Million
Q4 2022

May 14, 2024
SELL
$16.95 - $25.07 $372 - $551
-22 Reduced 0.02%
111,293 $2.03 Million
Q4 2022

Feb 13, 2023
SELL
$16.95 - $25.07 $372 - $551
-22 Reduced 0.02%
111,293 $2.03 Million
Q3 2022

May 14, 2024
BUY
$14.64 - $26.7 $474,980 - $866,254
32,444 Added 41.14%
111,315 $2.53 Million
Q3 2022

Nov 10, 2022
BUY
$14.64 - $26.7 $474,980 - $866,254
32,444 Added 41.14%
111,315 $2.53 Million
Q2 2022

May 14, 2024
SELL
$10.54 - $24.2 $24.5 Million - $56.2 Million
-2,323,028 Reduced 96.72%
78,871 $1.09 Million
Q2 2022

Aug 15, 2022
BUY
$10.54 - $24.2 $57,063 - $131,018
5,414 Added 7.37%
78,871 $1.09 Million
Q1 2022

May 16, 2022
BUY
$20.81 - $37.29 $167,853 - $300,781
8,066 Added 12.34%
73,457 $1.67 Million
Q4 2021

Feb 14, 2022
SELL
$32.99 - $58.55 $2.17 Million - $3.85 Million
-65,709 Reduced 50.12%
65,391 $2.44 Million
Q3 2021

Nov 10, 2021
BUY
$42.03 - $60.5 $5.51 Million - $7.93 Million
131,100 New
131,100 $5.55 Million

Others Institutions Holding BLFS

# of Institutions
189
Shares Held
46.4M
Call Options Held
8.2K
Put Options Held
4K
View Full List

About BIOLIFE SOLUTIONS INC

BLFS Quotes by TradingView
  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.16B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email